Tetra Tech ( TTEK) upgraded at BMO from Market Perform to Outperform, BMO Capital said. $30 price target. Company should see an improving order cycle, given more faster-growing private clients.

STOCK COMMENTS / EPS CHANGES

Apple ( AAPL) target raised at Needham to $620. iPad popularity is also driving Mac sales.

Agrium ( AGU) estimates, target boosted at Goldman. Shares of AGU now seen reaching $85, according to Goldman Sachs. Estimates also upped, as the company is seeing higher retail demand. Neutral rating.

Akamai Technologies ( AKAM) target raised at Jefferies. Shares of AKAM now seen reaching $41, Jefferies said. Holiday / traffic combine for a very strong fourth quarter. Hold rating.

Akamai estimates, target raised at Credit Suisse. Shares of AKAM now seen reaching $25, according to Credit Suisse. Estimates also increased, to match the company's new guidance. Neutral rating.

American Express ( AXP) numbers boosted at Morgan Stanley. Shares of AXP now seen reaching $56, according to Morgan Stanley. Estimates also upped, as the company is gaining market share online. Equal-weight rating.

Compass Minerals ( CMP) numbers cut at Goldman. CMP estimates were reduced through 2013, Goldman Sachs said. Company is being hurt by the mild winter. Sell rating and new $77 price target.

Cisco Systems ( CSCO) numbers upped at Goldman. CSCO estimates were boosted through 2014, Goldman Sachs said. Company is seeing higher sales and cutting costs. Buy rating and new $25 price target.

Cisco Systems numbers raised at Oppenheimer. Shares of CSCO now seen reaching $23, Oppenheimer said. Estimates also raised on strong January quarter. Outperform rating.

Cisco Systems numbers raised at UBS. Shares of CSCO now seen reaching $24, according to UBS. Estimates also increased on strong 2Q execution. Buy rating.

Cognizant ( CTSH) estimates, target raised at Goldman. Shares of CTSH now seen reaching $73, according to Goldman Sachs. Estimates also increased, given higher offshore growth. Neutral rating.

CVS/Caremark ( CVS) numbers raised at Morgan Stanley. Shares of CVS now seen reaching $48, according to Morgan Stanley. Estimates also increased, as the company is gaining market share. Overweight rating.

Gildan Activewear ( GIL) numbers boosted at Goldman. Shares of GIL now seen reaching $18, according to Goldman Sachs. Estimates also upped, as the company is seeing higher sales. Neutral rating.

If you liked this article you might like

Hewlett Packard Enterprise Becomes the Latest Tech Titan to Slash Jobs

7 Essential Rules for Investing in Tech Stocks

Tax Reform Is Coming and That Means Trump Stock Rally Is Ready to Kill It Again

'Trump Stock' Rally Is Back on Track

These Stocks Pay You to Own Them